Navigation Links
Nick Childs Joins Grey New York as Director of Content Development
Date:9/11/2007

won the Tribeca Film

Festival 2006 Award for Best Narrative Short, among many honors. The

film played at 50 festivals and hit number one as most downloaded short

film on iTunes.

-- "High Score": He served as executive director of this feature length

documentary on die-hard video gamer, Bill Carlton. The film won awards

at SXSW and the Brooklyn Underground Film Festival.

-- Brady Campaign Against Gun Violence: He was the executive director of a

series of documentaries marking the anniversary of the Brady Bill,

featuring Jim and Sarah Brady.

He also served as a creative consultant to Christopher Reeve on ABC-TV's remake of Hitchcock's "Rear Window" and the HBO Film "In the Gloaming", directed by the star.

Nick graduated with a BA in English and Fiction Writing from Colby College and received a MFA from New York University.

About Grey

Grey New York is the flagship and largest office of Grey, a unit of Grey Group. Grey Group ranks among the largest global communications companies. Its parent company is WPP (Nasdaq: WPPGY). Grey Group's total offer includes G2, activation marketing; Grey Healthcare Group, healthcare communications; MediaCom, media planning and buying and GCI Group, public relations. Grey New York's blue-chip client roster includes many of the world's best known companies: Procter & Gamble, GlaxoSmithKline, BAT, Diageo, Darden Restaurants, Wyeth, Canon, 3M, Eli Lilly and Dairy Queen.


'/>"/>
SOURCE Grey New York
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The Best Way To Get Your Childs Attention
2. Dads Age Found To Affect The Childs Risk for Schizophrenia
3. Strengthen Your Childs Immunity Give Him A Cat
4. Mothers Diet During Pregnancy Affects Childs Behavior
5. A New Study Shows Social Well Being Plays An Important Part In Childs Health
6. An International Growth Standard For Childs Releases By WHO
7. Second Hand Smoke Has Serious Consequence on a Childs Heart
8. Court Seeks Explanation from Hospital for Childs Amputation
9. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
10. Rat joins list of cloned animals
11. Richard Gere Joins Indian Stars For Fight Against AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:NeuroFocus Adds Two More of the World's Leading Neuroscientists to its Advisory Board 2Health News:NeuroFocus Adds Two More of the World's Leading Neuroscientists to its Advisory Board 3Health News:Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs 2Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 2Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 3Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 4Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 5Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 2Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 3Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 4Health News:Sushi & Breastfeeding Join Birth Defects & Preterm Birth as Leading Concerns of Moms 2
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3Sundia MediTech Appoints Dr Tong Xu as VP of Process Chemistry 12816 1Sundia MediTech Appoints Dr Tong Xu as VP of Process Chemistry 12816 2AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 1AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 2AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 3AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 4Tanning Chain Offers Tips for Effective Indoor and Outdoor Exposure 50246 1Tanning Chain Offers Tips for Effective Indoor and Outdoor Exposure 50246 2